# Stryker Neurovascular – FDA Inspection, Dec 18, 2024

Source: https://www.keypedia.com/records/fda_inspections/stryker-neurovascular/8d0493c2-985c-4955-86c1-f6f0f5fa478d
Source feed: FDA_Inspections

> FDA inspection 1257117 of Stryker Neurovascular, December 18, 2024. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 812. Form 483 issued. 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1257117
- Company Name: Stryker Neurovascular
- Inspection Date: 2024-12-18
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Product Evaluation: Medical Devices
- Product Type: Medical Devices & Rad Health
- Center: Medical Devices & Rad Health
- Office Name: San Francisco District Office
- Citation Count: 1

## Related Documents

- [FDA Inspection 1028734 - 2017-10-16](https://www.keypedia.com/records/fda_inspections/stryker-neurovascular/830feb26-c340-4730-a20c-71c55f4e6fc9)
- FDA Inspection 1032404 - 2017-09-22
- FDA Inspection 980716 - 2016-06-01
- FDA Inspection 936471 - 2015-07-30
- FDA Inspection 851608 - 2013-10-15

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/kristin-m-abaonza/cf909da8-837d-4dfe-9ccc-288b24d7bba3)

Company: https://www.keypedia.com/companies/stryker-neurovascular/75d76f13-3dbc-4078-a970-3bf0cbbf5a7b

Office: https://www.keypedia.com/offices/san-francisco-district-office/6f838e9c-aae1-4665-9c46-a51d43be02df